T1	Citation 593 597	[20]
T2	Context 415 598	In contrast, the Basal-like and Claudin-low carcinomas are mostly triple negative breast cancers (ER-PR-Her2-) associated with high resistance to chemotherapy and poor prognosis [20].
T3	ACCURATE 2329 2632	Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation.
T4	ACCURATE 2633 2769	They also have a response rate to standard preoperative chemotherapy that is intermediate between that of basal-like and luminal tumors.
